BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 38567424)

  • 1. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
    Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
    Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
    Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study.
    Gupta P; Patterson BC; Chu L; Gold S; Amos S; Yeung H; Goodman M; Tangpricha V
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1236-e1244. PubMed ID: 37246711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of a transgender and gender-diverse patient population in Utah: Use of electronic health records to advance clinical and health equity research.
    Ho TF; Zenger B; Mark B; Hiatt L; Sullivan E; Steinberg BA; Lyons A; Spivak AM; Agarwal C; Adelman M; Hotaling J; Kiraly B; Talboys S
    PLoS One; 2024; 19(5):e0302895. PubMed ID: 38713697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Anogenital Gonorrhea and Chlamydia in Transgender and Gender Diverse Primary Care Patients Receiving Gender-Affirming Hormone Therapy.
    Reisner SL; Deutsch MB; Mayer KH; Pletta DR; Campbell J; Potter J; Keuroghlian AS; Hughto JMW; Asquith A; Pardee DJ; Harris A; Quint M; Grasso C; Gonzalez A; Radix A
    J Gen Intern Med; 2024 May; 39(7):1164-1172. PubMed ID: 37989820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gender-affirming hormone therapy on body fat: a retrospective case‒control study in Chinese transwomen.
    Pei Q; Song Y; Huang Z; Yu H; Xu H; Ye X; Gao L; Gong J; Tian X
    Lipids Health Dis; 2024 May; 23(1):146. PubMed ID: 38760846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronotype changes after sex hormone use: A prospective cohort study in transgender users of gender-affirming hormones.
    Morssinkhof MWL; Zwager A; van der Tuuk K; den Heijer M; van der Werf YD; Stenvers DJ; Broekman BFP
    Chronobiol Int; 2024 May; 41(5):658-668. PubMed ID: 38616311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV.
    Martinez CA; Rikhi R; Fonseca Nogueira N; Pester MS; Salazar AS; Ashinne B; Aguilar N; Melara A; Porras V; Parker M; Mendez A; Cyrus E; De Santis JP; Jones DL; Brown TT; Hurwitz BE; Alcaide ML
    LGBT Health; 2023; 10(8):576-585. PubMed ID: 37459150
    [No Abstract]   [Full Text] [Related]  

  • 9. Referrals For Gender-Affirming Hormone Treatment in Croatia's National Network for Transgender Healthcare.
    Altabas V; Galjuf V; Žegura I; Jokić Begić N; Moravek D; Arbanas G; Begić D
    Arch Sex Behav; 2024 Jun; 53(6):2045-2052. PubMed ID: 38691268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between gender-affirming hormone therapy and measures of glucose metabolism: A longitudinal study.
    Anike O; Zhang Q; Bhasin S; Flanders WD; Getahun D; Haw JS; Huybrechts KF; Lash TL; McCracken CE; Roblin D; Silverberg MJ; Suglia SF; Tangpricha V; Vupputuri S; Goodman M
    J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38815002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fit Transitioning: When Can Transgender Airmen Fitness Test in Their Affirmed Gender?
    Chiccarelli E; Aden J; Ahrendt D; Smalley J
    Mil Med; 2023 Jul; 188(7-8):e1588-e1595. PubMed ID: 36271916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Gender Affirming Hormone Therapy Increase the Risk of Kidney Disease?
    Eckenrode HE; Carwie JC; Curtis LM
    Semin Nephrol; 2022 May; 42(3):151284. PubMed ID: 36435684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to the Patient: Hormonal Therapy in Transgender Adults With Complex Medical Histories.
    Iwamoto SJ; Rothman MS; T'Sjoen G; Defreyne J
    J Clin Endocrinol Metab; 2024 Jan; 109(2):592-602. PubMed ID: 37683089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Distinct Anti-Androgen Exposures on the Plasma Metabolome in Feminizing Gender-Affirming Hormone Therapy.
    Shepherd R; Angus LM; Mansell T; Arman B; Kim BW; Lange K; Burgner D; Kerr JA; Pang K; Zajac JD; Saffery R; Cheung A; Novakovic B
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38609170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Utility of Preclinical Models in Understanding the Bone Health of Transgender Individuals Undergoing Gender-Affirming Hormone Therapy.
    Venkatesh VS; Nie T; Zajac JD; Grossmann M; Davey RA
    Curr Osteoporos Rep; 2023 Dec; 21(6):825-841. PubMed ID: 37707757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of gender-affirming hormone therapy and mastectomy on psychopathology, body image, and quality of life in adults with gender dysphoria who were assigned female at birth.
    Turan Ş; Özulucan MT; Karataş U; Kavla Y; Koyuncu O; Durcan E; Durcan G; Bağhaki S
    Qual Life Res; 2024 Jul; 33(7):1937-1947. PubMed ID: 38656406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic risk associated with gender-affirming hormone therapy.
    Mullins TLK; Mullins ES
    J Thromb Haemost; 2024 May; ():. PubMed ID: 38795871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One person, many changes: a socioecological qualitative analysis of the experiences of transfeminine individuals undergoing feminising gender-affirming hormone therapy.
    Fowler JA; Warzywoda S; Reyment M; Crilly T; Franks N; Bisshop F; Wood P; Dean JA
    Cult Health Sex; 2024 Jun; ():1-17. PubMed ID: 38829652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximizing surgical outcomes with gender affirming hormone therapy in gender affirmation surgery.
    Gelles-Soto D; Ward D; Florio T; Kouzounis K; Salgado CJ
    J Clin Transl Endocrinol; 2024 Jun; 36():100355. PubMed ID: 38881950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations in gender-affirming hormone therapy in transgender and gender diverse patients undergoing liver transplantation.
    Nikzad N; Fisher AR; Pillai A; Targownik LE; Te HS; Aronsohn A; Paul S
    Am J Transplant; 2024 May; ():. PubMed ID: 38729612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.